

CLASSIFICATION: GROWTH HORMONE SECRETAGOGUE (GHRH ANALOG)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: APPROXIMATELY 30 MINUTES
DOSAGE: 1–2 MG DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
Peptide Hubs Tesamorelin 5 mg delivers a research-grade synthetic growth hormone-releasing hormone (GHRH) analog, designed to stimulate the natural production of growth hormone (GH). Each 2 mL vial contains 5 mg of Tesamorelin, produced under strict quality standards for consistent research use.
Tesamorelin is a stabilized analog of growth hormone-releasing hormone (GHRH) used in research to promote growth hormone secretion. It has been studied for reducing visceral fat, improving lipid profiles, and supporting anti-aging protocols [Clinical Study].
Research protocols typically involve subcutaneous administration of 1–2 mg daily, ideally administered before bedtime to mimic natural GH secretion cycles. Long-term research cycles (12+ weeks) are commonly employed. Professional supervision is strongly recommended for peptide research.
Boost your growth hormone research by combining Tesamorelin with Sermorelin by Peptide Hubs. Discover more cutting-edge peptides in the Peptide Hubs USA section.
Tesamorelin is used in research to stimulate natural growth hormone production, reduce visceral fat, improve metabolic profiles, and support anti-aging processes.
Research protocols often use 1–2 mg of Tesamorelin administered subcutaneously daily, ideally before bedtime to align with natural GH secretion rhythms.
Tesamorelin has demonstrated a favorable safety profile in clinical studies. Some users report mild side effects like fluid retention or joint stiffness. Research supervision is recommended.
You can purchase authentic Tesamorelin 5 mg from our Peptide Hubs USA section, featuring premium-grade peptides for research purposes.
Please log in to write TESAMORELIN 5 MG review.
CLASSIFICATION: GROWTH HORMONE RELEASING HORMONE (GHRH)
ACTIVE SUBSTANCE: TESAMORELIN
FORM: POWDER - 2 ML VIAL x 5 MG
ACTIVE HALF-LIFE: 20 TO 30 MINUTES
DOSAGE: MEN 1 TO 2 MG PER DAY
ACNE: RARE
WATER RETENTION: MINIMAL
HIGH BLOOD PRESSURE (HBP): N/A
HEPATOTOXICITY: NOT OBSERVED
AROMATIZATION: NONE
MANUFACTURER: DRAGON PHARMA
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (rHGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 PRE-FILLED PEN x 36 IU (12 MG)
ACTIVE HALF-LIFE: ~3.5 HOURS (SUBQ)
DOSAGE: 1–4 IU/DAY FOR ANTI-AGING; 4–8 IU/DAY FOR FAT LOSS OR PERFORMANCE
WATER RETENTION: POSSIBLE (DOSE DEPENDENT)
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PFIZER
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: HUMAN CHORIONIC GONADOTROPIN
FORM: 1 ML AMP x 5000 IU
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY ELEVATES ESTROGEN
MANUFACTURER: SUN PHARMA
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 10000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES
CLASSIFICATION: PEPTIDE HORMONE / HCG
ACTIVE SUBSTANCE: PRE-MIXED HUMAN CHORIONIC GONADOTROPIN
FORM: 1 VIAL x 5000 IU (READY-TO-INJECT)
ACTIVE HALF-LIFE: ~3–6 DAYS
DOSAGE: 250–1000 IU 2–3x/WEEK (ON-CYCLE or PCT)
ACNE: POSSIBLE
WATER RETENTION: LOW to MODERATE
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: INDIRECTLY INCREASES ESTROGEN
MANUFACTURER: BHARAT SERUMS AND VACCINES